Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Endoclot

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND Gastrointestinal (GI) bleeding is a common indication for endoscopy. For refractory cases, hemostatic powders (HP… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Review
2018
Review
2018
Despite the recent advances in endoscopic hemostatic techniques, the management of lower gastrointestinal bleeding could be… Expand
2016
2016
Background and Study Aims: Hemostatic powders have been introduced to improve the management of gastrointestinal (GI) bleeding… Expand
2015
2015
Background and study aims: EndoClot is a novel topical hemostatic powder approved for use in non-variceal upper gastrointestinal… Expand
  • table 1
2015
2015
Absorbable modified polymer (AMP) is a novel local haemostatic agent derived from a natural polysaccharide. Its safety and… Expand
2014
2014
Introduction Endoclot’ (EPI) and ‘Hemospray’ (Wilson Cook) are haemostatic powders marketed for endoscopic use. The powders… Expand
2014
2014
Introduction Endoclot™ is a non-toxic topical haemostatic powder consisting of absorbable modified polymers. We previously… Expand
2013
2013
Introduction EndoClot™ is a new novel haemostatic powder for the treatment of gastrointestinal bleeding. We report our initial… Expand